Investment
Features
FeesSafety
Academy
More
Pluang+

ATI CEO Kim Fields to discuss aerospace growth and ATI's unique capabilities at Morgan Stanley conference

Market News
14 Sep 2026
PRNewsWire
View Source
Neutral
ATI CEO Kim Fields to discuss aerospace growth and ATI's unique capabilities at Morgan Stanley conference

Kim Fields, CEO of ATI Inc., will speak at the Morgan Stanley 14th Annual Laguna Conference on September 17, 2026. She will discuss aerospace opportunities and the growing value of ATI's specialized materials and technologies. ATI is known for producing high-performance materials that support aerospace and defense industries, helping products perform better in extreme conditions. The event will be webcast live, with a replay and transcript available afterward.

Kim Fields, CEO of ATI Inc., is set to speak at the Morgan Stanley 14th Annual Laguna Conference. For readers following Industrials-sector stocks, here is Pluang's market snapshot as of Sep 15, 2026 03:21 WIB: of 75 priced US Industrials-sector stocks, 38 rose and 36 fell. Notable movers include Booz Allen Hamilton Holding Corporation (BAH) at USD 79.27 with a +4.44% change, Caterpillar Inc (CAT) at USD 784.18 with a -4.20% change, and Dolby Laboratories, Inc. (DLB) at USD 61.91 with a -3.98% change.

More News

Hormel Foods price target cut to $23 amid hopes for valuation rebound despite 50% share drop.

Hormel Foods price target cut to $23 amid hopes for valuation rebound despite 50% share drop.

BNP Paribas lowered Hormel Foods' price target from $26 to $23, indicating a potential 16.2% upside from its current price of around $19.80. Despite a 50.5% decline in its share price over five years, Hormel Foods remains attractive for dividend inve...

Analyst Insights
Neutral
1 hour ago
Barclays rates Becton Dickinson 'Underweight' amid $3B U.S. manufacturing partnership

Barclays rates Becton Dickinson 'Underweight' amid $3B U.S. manufacturing partnership

Barclays initiated coverage of Becton, Dickinson and Company (BDX) with an "Underweight" rating, indicating a cautious outlook for the medical technology stock. BDX is partnering with the U.S. government to boost domestic manufacturing and strengthen...

Market News
Bearish
1 hour ago
Morgan Stanley raises Eli Lilly price target to $1,430, signaling 20.8% potential upside.

Morgan Stanley raises Eli Lilly price target to $1,430, signaling 20.8% potential upside.

Morgan Stanley increased its price target for Eli Lilly to $1,430 from $1,419, maintaining an Overweight rating. This new target implies a potential upside of about 20.8% from the current share price of around $1,184. The adjustment reflects updated ...

Analyst Insights
Bullish
2 hours ago
Arthur J. Gallagher sees 6% organic growth; analysts split on price targets amid mixed outlook.

Arthur J. Gallagher sees 6% organic growth; analysts split on price targets amid mixed outlook.

Arthur J. Gallagher expects about 6% organic growth in Q3, driven by strong client retention and new business despite easing property insurance pricing. Cantor Fitzgerald lowered its price target to $280, below the $288 average from 19 analysts who m...

Analyst Insights
Bullish
3 hours ago
Zscaler's price target raised to $255 on strong AI-driven cybersecurity demand and growth outlook.

Zscaler's price target raised to $255 on strong AI-driven cybersecurity demand and growth outlook.

Needham raised Zscaler's price target to $255, citing strong demand for AI-related cybersecurity solutions. Zscaler aims to exceed $8 billion in annual recurring revenue by fiscal 2031, driven by increasing needs to protect against AI-powered cyberat...

Analyst Insights
Bullish
3 hours ago
banner-footerbanner-footer

Invest & Trade with
#1 Award-Winning Investment Super App